GlassScriptPhysician profile
Kimberly A Gerten
NPI 1083658181
$1,780.16
in general payments reported to CMS, 2019-2025
15 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $198 · 2020: $16.72 · 2021: $101 · 2022: $520 · 2023: $378 · 2024: $373 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $944.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $938.43 | 2021-2024 | Axonics |
| Medtronic, INC. | $240.16 | 2021-2024 | Interstim |
| Boston Scientific Corporation | $172.76 | 2025 | Axonics |
| Urocure LLC | $72.94 | 2019 | |
| Astellas Pharma US INC | $55.97 | 2019-2023 | Veozah |
| Exact Sciences Corporation | $54.93 | 2023-2025 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $45.44 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $43.68 | 2019-2023 | |
| Hologic Sales and Service, LLC | $39.68 | 2019-2024 | Novasure, Acessa Provu System |
| Ethicon US, LLC | $32.66 | 2019 | |
| Coloplast Corp | $23.92 | 2019 | |
| Pfizer INC. | $16.46 | 2023 | |
| Gynesonics, INC. | $16.21 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $13.74 | 2023 | |
| Organon LLC | $13.18 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Gerten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.